UP!
| 2016-03-15 | Boost Price Target | Aegis | Buy | $8.00 to $15.00 |
| 2016-03-11 | Reiterated Rating | Janney Montgomery Scott | Buy to Neutral | |
| 2016-01-26 | Reiterated Rating | Aegis | Buy | |
| 2015-10-06 | Reiterated Rating | Aegis | Positive | |
| 2015-05-14 | Reiterated Rating | Cantor Fitzgerald | Buy | $13.00 |
| 2015-04-09 | Initiated Coverage | Janney Montgomery Scott | Buy to Buy | $13.00 |
| 2015-03-15 | Reiterated Rating | Cantor Fitzgerald | Buy | $13.00 |
| 2014-08-14 | Reiterated Rating | Cantor Fitzgerald | Buy | $30.00 to $25.00 |
| 2014-05-16 | Lower Price Target | Cantor Fitzgerald | $21.00 to $18.00 | |
| 2014-04-01 | Initiated Coverage | Cantor Fitzgerald | Buy | $21.00 |
| 2013-11-14 | Lower Price Target | Feltl & Co. | Strong-Buy | $30.50 to $24.00 |
| 2013-11-14 | Boost Price Target | Aegis | Buy | $25.00 to $32.50 |
| 2013-10-02 | Boost Price Target | Feltl & Co. | Strong-Buy | $17.50 to $30.50 |
| 2013-09-26 | Initiated Coverage | Aegis | Buy | $25.00 |
| 2016-03-15 | Boost Price Target | Aegis | Buy | $8.00 to $15.00 |
| 2016-03-11 | Reiterated Rating | Janney Montgomery Scott | Buy to Neutral | |
| 2016-01-26 | Reiterated Rating | Aegis | Buy | |
| 2015-10-06 | Reiterated Rating | Aegis | Positive | |
| 2015-05-14 | Reiterated Rating | Cantor Fitzgerald | Buy | $13.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CGIX 6 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Quality Growth Management, Inc. | 0.23M |
| GRUBER & MCBAINE CAPITAL MANAGEMENT LLC | 92800 |
| BlackRock Fund Advisors | 37660 |
| BlackRock Institutional Trust Company, N.A. | 12424 |
| BlackRock Investment Management, LLC | 2086 |
| LADENBURG THALMANN FINANCIAL SERVICES INC | 215 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| PAPPAJOHN JOHN | 28.68% (2781204) | ANCI / CGIX / HH / PIP / |
| SHARMA PANNA Chief Executive Officer | 1.57% (152500) | CGIX / |
| Chaganti Raju S.K. | 1.49% (144071) | CGIX / |
| Harris Geoffrey E. | 0.28% (27500) | ANCI / CGIX / |
| Cannon Edmund | 0.19% (18394) | CGIX / |
| Sitar Edward J Chief Financial Officer | 0.18% (17500) | CGIX / |
| McLeod Howard | 0.14% (13500) | CGIX / |
| Welsh Michael J. | 0.13% (12540) | CGIX / |
| PRENDERGAST FRANKLYN G | 0.13% (12500) | CGIX / LLY / |
| ROBERTS JOHN A Chief Operating Officer | 0.13% (12200) | CGIX / |
| Rothman Paul | 0.05% (5000) | CGIX / MRK / |
| Brownlie Keith L | 0.05% (5000) | CGIX / CLDX / IMNP / RXII / SNGX / |
| Hepburn Steven VP of Biopharma Marketing | 0.03% (3000) | CGIX / |
| Shaknovich Rita VP of Hematopathology Services | 0.03% (3000) | CGIX / |
| Thompson Tommy G | 0.03% (2500) | BCR / CGIX / CNC / CYTX / DOC / PURE / TXMD / UTHR / |
| Pecora Andrew L | 0.02% (2391) | CGIX / NBS / TLOG / |
| Gitelman Igor Chief Accounting Officer | 0.01% (937) | CGIX / |
UM